RecruitingNot ApplicableNCT06647017

Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

Sponsor

University Surgical Vascular

Enrollment

40 participants

Start Date

Nov 13, 2024

Study Type

INTERVENTIONAL

Conditions

Blood Loss, Surgical

Summary

The objective of this study is to determine if tAN therapy can reduce the volume of blood lost during dialysis AV graft placement procedures.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called SHAM Volta tAN System and a medical device called Volta tAN System for people with blood loss, surgical. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.